552 related articles for article (PubMed ID: 15173268)
1. Evaluation of carcinogen exposure in people who used "reduced exposure" tobacco products.
Hatsukami DK; Lemmonds C; Zhang Y; Murphy SE; Le C; Carmella SG; Hecht SS
J Natl Cancer Inst; 2004 Jun; 96(11):844-52. PubMed ID: 15173268
[TBL] [Abstract][Full Text] [Related]
2. Effect of oral snus and medicinal nicotine in smokers on toxicant exposure and withdrawal symptoms: a feasibility study.
Kotlyar M; Hertsgaard LA; Lindgren BR; Jensen JA; Carmella SG; Stepanov I; Murphy SE; Hecht SS; Hatsukami DK
Cancer Epidemiol Biomarkers Prev; 2011 Jan; 20(1):91-100. PubMed ID: 21068204
[TBL] [Abstract][Full Text] [Related]
3. Effects of reduced cigarette smoking on the uptake of a tobacco-specific lung carcinogen.
Hecht SS; Murphy SE; Carmella SG; Zimmerman CL; Losey L; Kramarczuk I; Roe MR; Puumala SS; Li YS; Le C; Jensen J; Hatsukami DK
J Natl Cancer Inst; 2004 Jan; 96(2):107-15. PubMed ID: 14734700
[TBL] [Abstract][Full Text] [Related]
4. Metabolites of a tobacco-specific nitrosamine, 4-(methylnitrosamino)- 1-(3-pyridyl)-1-butanone (NNK), in the urine of smokeless tobacco users: relationship between urinary biomarkers and oral leukoplakia.
Kresty LA; Carmella SG; Borukhova A; Akerkar SA; Gopalakrishnan R; Harris RE; Stoner GD; Hecht SS
Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):521-5. PubMed ID: 8827356
[TBL] [Abstract][Full Text] [Related]
5. Similar exposure to a tobacco-specific carcinogen in smokeless tobacco users and cigarette smokers.
Hecht SS; Carmella SG; Murphy SE; Riley WT; Le C; Luo X; Mooney M; Hatsukami DK
Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1567-72. PubMed ID: 17684130
[TBL] [Abstract][Full Text] [Related]
6. Randomised clinical trial of snus versus medicinal nicotine among smokers interested in product switching.
Hatsukami DK; Severson H; Anderson A; Vogel RI; Jensen J; Broadbent B; Murphy SE; Carmella S; Hecht SS
Tob Control; 2016 May; 25(3):267-74. PubMed ID: 25991608
[TBL] [Abstract][Full Text] [Related]
7. Metabolites of a tobacco-specific lung carcinogen in nonsmoking women exposed to environmental tobacco smoke.
Anderson KE; Carmella SG; Ye M; Bliss RL; Le C; Murphy L; Hecht SS
J Natl Cancer Inst; 2001 Mar; 93(5):378-81. PubMed ID: 11238699
[TBL] [Abstract][Full Text] [Related]
8. Analysis of human urine for pyridine-N-oxide metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific lung carcinogen.
Carmella SG; Borukhova A; Akerkar SA; Hecht SS
Cancer Epidemiol Biomarkers Prev; 1997 Feb; 6(2):113-20. PubMed ID: 9037562
[TBL] [Abstract][Full Text] [Related]
9. Similar uptake of lung carcinogens by smokers of regular, light, and ultralight cigarettes.
Hecht SS; Murphy SE; Carmella SG; Li S; Jensen J; Le C; Joseph AM; Hatsukami DK
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):693-8. PubMed ID: 15767351
[TBL] [Abstract][Full Text] [Related]
10. Nicotine and Toxicant Exposure among U.S. Smokeless Tobacco Users: Results from 1999 to 2012 National Health and Nutrition Examination Survey Data.
Rostron BL; Chang CM; van Bemmel DM; Xia Y; Blount BC
Cancer Epidemiol Biomarkers Prev; 2015 Dec; 24(12):1829-37. PubMed ID: 26582044
[TBL] [Abstract][Full Text] [Related]
11. Potential reduced exposure products (PREPs) for smokeless tobacco users: clinical evaluation methodology.
Gray JN; Breland AB; Weaver M; Eissenberg T
Nicotine Tob Res; 2008 Sep; 10(9):1441-8. PubMed ID: 19023835
[TBL] [Abstract][Full Text] [Related]
12. A comparison of urinary biomarkers of tobacco and carcinogen exposure in smokers.
Murphy SE; Link CA; Jensen J; Le C; Puumala SS; Hecht SS; Carmella SG; Losey L; Hatsukami DK
Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1617-23. PubMed ID: 15466978
[TBL] [Abstract][Full Text] [Related]
13. A two-site, two-arm, 34-week, double-blind, parallel-group, randomized controlled trial of reduced nicotine cigarettes in smokers with mood and/or anxiety disorders: trial design and protocol.
Allen SI; Foulds J; Pachas GN; Veldheer S; Cather C; Azzouz N; Hrabovsky S; Hameed A; Yingst J; Hammett E; Modesto J; Krebs NM; Zhu J; Liao J; Muscat JE; Richie J; Evins AE
BMC Public Health; 2017 Jan; 17(1):100. PubMed ID: 28103841
[TBL] [Abstract][Full Text] [Related]
14. Tobacco Consumption and Toxicant Exposure of Cigarette Smokers Using Electronic Cigarettes.
Pulvers K; Emami AS; Nollen NL; Romero DR; Strong DR; Benowitz NL; Ahluwalia JS
Nicotine Tob Res; 2018 Jan; 20(2):206-214. PubMed ID: 28003511
[TBL] [Abstract][Full Text] [Related]
15. Exposure to a Tobacco-Specific Carcinogen Among Adolescent Smokeless Tobacco Users in Rural California, United States.
Chaffee BW; Jacob P; Couch ET; Benowitz NL
Nicotine Tob Res; 2020 Oct; 22(10):1764-1771. PubMed ID: 31504879
[TBL] [Abstract][Full Text] [Related]
16. Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation.
Hecht SS; Carmella SG; Chen M; Dor Koch JF; Miller AT; Murphy SE; Jensen JA; Zimmerman CL; Hatsukami DK
Cancer Res; 1999 Feb; 59(3):590-6. PubMed ID: 9973205
[TBL] [Abstract][Full Text] [Related]
17. A study to evaluate the effect on Mouth Level Exposure and biomarkers of exposure estimates of cigarette smoke exposure following a forced switch to a lower ISO tar yield cigarette.
Shepperd CJ; Eldridge AC; Errington G; Dixon M
Regul Toxicol Pharmacol; 2011 Dec; 61(3 Suppl):S13-24. PubMed ID: 21672597
[TBL] [Abstract][Full Text] [Related]
18. Exposure to Toxicants Associated With Use and Transitions Between Cigarettes, e-Cigarettes, and No Tobacco.
Dai H; Benowitz NL; Achutan C; Farazi PA; Degarege A; Khan AS
JAMA Netw Open; 2022 Feb; 5(2):e2147891. PubMed ID: 35142830
[TBL] [Abstract][Full Text] [Related]
19. Toxicant exposure in cigarette reducers versus light smokers.
Hatsukami DK; Le CT; Zhang Y; Joseph AM; Mooney ME; Carmella SG; Hecht SS
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2355-8. PubMed ID: 17164356
[TBL] [Abstract][Full Text] [Related]
20. Quantitation of metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone after cessation of smokeless tobacco use.
Hecht SS; Carmella SG; Ye M; Le KA; Jensen JA; Zimmerman CL; Hatsukami DK
Cancer Res; 2002 Jan; 62(1):129-34. PubMed ID: 11782369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]